Salmonella Enterica spp.
Including serotypes: Typhi, Paratyphi, Enteriditis, Typhimurium and Choleraesuis
Morphology | Member of the Enterobacteriaceae family. Is a facultative anaerobe and is a gram negative motile rod shaped bacteria. |
---|---|
Disease |
Gastroenteritis, bacteremia, enteric fever, and asymptomatic carriers. |
Zoonosis | Yes - contact with infected animals and feces. |
Host Range | Humans and Animals. |
---|---|
Modes of Transmission | Contaminated food and water, contact with infected feces, infected animals or humans. |
Signs and Symptoms | Gastroenteritis (food poisoning), fever, abdominal pain, myalgias, malaise, diarrhea, or constipation. |
Infectious Dose | 1000 to 100000 |
Incubation Period | Ranges from 5 to 72 hours depending on the incubation period. |
Prophylaxis | None available |
---|---|
Vaccines | Three vaccines (2 parenteral and 1 oral) are licensed for use in the US and should be considered for those working with serotype Typhi |
Treatment | Chloramphenicol, ciproflaxin, amoxicillin, cotrimoxazole, trimethoprim-sulfonamid, cephalosporins and norfloxacin. |
Surveillance | Monitor for symptoms of infection |
MSU Requirements | Report any exposures |
Laboratory Acquired Infections (LAIs) | 64 cases and 2 deaths were reported from 1979 to 2004. |
---|---|
Sources | Blood, urine, feces, food and environmental materials. Cultures, frozen stocks, other samples described in IBC protocol. |
Canadian MSDS: | http://www.phac-aspc.gc.ca/lab-bio/res/psds-ftss/index-eng.php |
---|---|
BMBL
|
https://www.cdc.gov/labs/BMBL.html |
CDC
|
https://www.cdc.gov/salmonella/index.html |
NIH Guidelines
|
https://osp.od.nih.gov/wp-content/uploads/NIH_Guidelines.pdf |
Risk Group 2
|
Agents that are associated with human disease which is rarely serious and for which preventive or therapeutic interventions are often available. |
---|---|
BSL2
|
For all procedures involving suspected or known infectious specimen or cultures.
|
ABSL2
|
For all procedures utilizing infected animals.
|
Small
|
Notify others working in the lab. Remove PPE and don new PPE. Cover area of the spill
with absorbent material and add fresh 1:10 bleach:water. Allow 20 munutes (or as directed)
of contact time. After 20 minutes, cleanup and dispose of materials.
|
---|---|
Large
|
|
Mucous membrane
|
Flush eyes, mouth, or nose for 5 minutes at eyewash station.
|
---|---|
Other Exposures
|
Wash area with soap and water for 5 minutes.
|
Reporting |
Immediately report incident to supervisor, complete a First Report of Injury form, and submit to Safety and Risk Management.
|
Medical Follow-up
|
During business hours: Bridger Occupational Health 3406 Laramie Drive. Weekdays 8am -6pm. Weekends 9am-5pm
After business hours: Bozeman Deaconess Hospital Emergency Room 915 Highland Blvd Bozeman, MT |
Disinfection | Susceptible to 1:10 bleach:water, 70 % ethanol and 2 % gluteraldehyde |
---|---|
Inactivation | Inactivated by moist heat (15 minutes at 121° C) and dry heat (1 hour at 170° C). |
Survival Outside Host | Can survive in cattle slurry for 19-60 days, cattle manure for 48 days, soil for 231 days, and water for up to 152 days. Survive on fingertips for 80 minutes. |
Minimum PPE Requirements
|
Lab coat, disposable gloves, safety glasses, closed toed shoes, long pants
|
---|---|
Additional Precautions
|
Additioanl PPE may be required depending on lab specific SOPs and IBC Protocol. |